Aroa Biosurgery Limited (ASX:ARX)
Australia · Delayed Price · Currency is AUD 0.6400
+0.0100 (1.59%)
Aug 1, 2025, 4:10 PM AEST
Accolade Revenue
In the fiscal year ending March 31, 2025, Aroa Biosurgery had annual revenue of 84.70M NZD with 22.63% growth. Aroa Biosurgery had revenue of 45.54M in the half year ending March 31, 2025, with 33.85% growth.
Revenue
84.70M NZD
Revenue Growth
+22.63%
P/S Ratio
2.87
Revenue / Employee
n/a
Employees
n/a
Market Cap
220.82M USD
Revenue Chart
* This company reports financials in NZD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 84.70M | 15.63M | 22.63% |
| Mar 31, 2024 | 69.07M | 5.71M | 9.01% |
| Mar 31, 2023 | 63.36M | 23.68M | 59.68% |
| Mar 31, 2022 | 39.68M | 17.34M | 77.60% |
| Mar 31, 2021 | 22.34M | -2.73M | -10.90% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Ramsay Health Care | 17.12B |
| Telix Pharmaceuticals | 783.21M |
| Ansell | 3.00B |
| Mesoblast | 9.16M |
Aroa Biosurgery News
- 8 months ago - Aroa Biosurgery Ltd (ASX:ARX) H1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... - GuruFocus